论文部分内容阅读
目的观察Partner药物洗脱支架在急诊经皮冠状动脉介入治疗(PCI)中的临床疗效。方法选择行急诊PCI的患者68例,分为Partner支架组和Cypher支架组,比较PCI术后即刻最小管腔直径,术后6个月复查冠状动脉造影,比较两组患者的再狭窄率。结果Partner支架组术后即刻最小管腔直径为(3.1±0.8)mm,Cypher支架组为(3.1±0.3)mm,两组相比差异无统计学意义(P>0.05);6个月冠状动脉造影显示再狭窄率Partner支架组为4%,Cypher支架组为3%,两组相比差异无统计学意义。结论在急诊PCI中,应用Partner药物洗脱支架安全有效。
Objective To observe the clinical efficacy of Partner drug eluting stent in emergency percutaneous coronary intervention (PCI). Methods Sixty-eight patients undergoing PCI were divided into two groups: the Partner stent group and the Cypher stent group. The diameter of the smallest lumen immediately after PCI was compared. Coronary angiography was performed 6 months after the operation. The restenosis rate was compared between the two groups. Results The smallest diameter of the lumen of the stent was (3.1 ± 0.8) mm in the stent group and (3.1 ± 0.3) mm in the Cypher stent group after operation. There was no significant difference between the two groups (P> 0.05) Angiography showed that the restenosis rate was 4% in the Partner stent group and 3% in the Cypher stent group, with no significant difference between the two groups. Conclusion It is safe and effective to use Partner drug-eluting stent in emergency PCI.